Rokit Healthcare (376900.KQ) Stock Price

Rokit Healthcare Inc develops and sells medical supplies and pharmaceutical products through its AI organ regeneration platform. The company offers three core services: medical 3-dimensional (3D) bioprinting using biocompatible materials, AI automated precision modeling for affected areas, and disposable medical device kits for assembly and disassembly. These services target healthcare providers and medical institutions seeking advanced solutions for organ regeneration and precision medical procedures. The firm also engages in manufacturing, development, sales, wholesale, and retail of medical devices, supporting both domestic and international markets. The medical 3D bioprinting service creates 3D structures with biomaterials, while the AI automated precision modeling service uses artificial intelligence to model affected areas accurately. Disposable medical device kits are sterile and designed for direct assembly and disassembly, catering to hospitals and clinics requiring efficient, sterile medical tools. Rokit Healthcare Inc's business model focuses on delivering integrated AI-driven medical solutions that combine bioprinting, modeling, and disposable device kits to enhance patient care and surgical precision. Rokit Healthcare Inc's primary revenue streams come from the sale of its AI organ regeneration platform services and the associated medical devices. Healthcare providers and medical institutions purchase these services and products to improve treatment outcomes and streamline surgical processes. The company's manufacturing and distribution activities in medical devices further contribute to its revenue, with a strong emphasis on innovation in AI and bioprinting technologies to maintain market competitiveness.